Gary Kaiser

Vice President of Global Marketing

Mr. Kaiser joined Viveve in 2019 and assumed the leadership role as Vice President of Global Marketing in January 2021. He has more than 25 years of senior management experience in the health care, pharmaceutical, and medical device industries. Prior to joining Viveve, Mr. Kaiser worked at Aytu BioScience from July 2016 to January 2019, where he was instrumental in the organization’s entrance into the urology market. Preceding Aytu BioScience, he served as Director of Marketing at Astellas Pharmaceuticals, Inc. where he led the professional marketing launch in 2012 of Myrbetriq®, the first beta-3 agonist drug for overactive bladder. Additional professional experience includes marketing roles at Amgen, TAP Pharmaceuticals, Pharmacia, Knoll Pharmaceutical Company, and a family-owned home health care company. During this tenure, Gary gained extensive management experience launching numerous biotech and consumer products, building brands, and developing organizations for commercial success in various therapeutic areas.

Mr. Kaiser received a B.S. in Marketing and an M.B.A. in Marketing from the University of Montana.

Interested in learning more about investing?

Go to Viveve's Investor Site

Product Indications

Viveve System
The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States.
Viveve Solutions
The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States. The InControl Products (InToneMV) is indicated for the treatment of all forms of urinary incontinence in the United States and Canada.